Eli Lilly and (LLY)

Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with Donald Trump's administration to lower drug prices ...

There are several compelling reasons to invest in pharmaceutical companies, especially when the economy isn't doing well. Since they belong to a defensive industry, drugmakers tend to perform better t...

Eli Lilly (LLY) stock merits your attention. Why? Because it offers monopoly-like high margins at a reduced price.

Telehealth company HealthTap said on Wednesday it is joining Eli Lilly's digital healthcare platform, LillyDirect, to offer virtual diabetes management services.

Oracle (ORCL -2.43%) quietly transformed itself over the past couple of years from an aging database giant into a critical enabler of the global artificial intelligence (AI) infrastructure buildout. W...

Peter Marks, the former top vaccine regulator at the U.S. Food and Drug Administration, has joined Eli Lilly , STAT News reported on Tuesday.

Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

After tanking in early August, the world's most valuable pharmaceutical stock has roared back with a vengeance. That firm is Eli Lilly and Company NYSE: LLY, the maker of the wildly popular weight los...

LLY shares have jumped 16% last week as Pfizer's landmark government deal boosted investor confidence across the pharma sector.